Skip to main content

Advertisement

SpringerLink
Log in

Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Introduction

Sinonasal tumors that harbor neuroendocrine histologic features include olfactory neuroblastoma (previously known as esthesioneuroblastoma), sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma. These tumors represent a diverse spectrum of clinical behavior and as such require histology-specific management. Herein, we review the management of these sinonasal tumors with neuroendocrine features and discuss fundamentals of multi-modality care for each histology. An emphasis is placed on olfactory neuroblastomas, given their relative frequency and skullbase origin.

Methods

A comprehensive literature review on contemporary management of olfactory neuroblastoma, sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma was performed.

Results

Management of sinonasal tumors with neuroendocrine features can include surgical resection, radiation therapy, and/or chemotherapy. Due to their site of origin, these tumors can frequently involve the skullbase, which can require site-specific care. The optimal treatment modalities and the sequence in which they are performed are largely dependent on histology. In most cases, olfactory neuroblastoma is best managed with surgical resection followed by radiation therapy. Sinonasal neuroendocrine carcinomas represent a variety of histologic phenotypes (carcinoid, atypical carcinoid, small cell, and large cell), which determine the optimal treatment modality. Finally, sinonasal undifferentiated carcinoma is likely best managed by induction chemotherapy with subsequent therapy dictated by the initial response.

Conclusions

A team approach to multi-modality care is essential in the treatment of olfactory neuroblastoma, sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma. Early biopsy, histologic diagnosis, and comprehensive imaging are critical to determining the appropriate management paradigm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dutta R, Dubal PM, Svider PF et al (2015) Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope 125:2491–2497. https://doi.org/10.1002/lary.25465

    Article  PubMed  Google Scholar 

  2. Bell D, Hanna EY, Weber RS et al (2016) Neuroendocrine neoplasms of the sinonasal region. Head Neck 38(Suppl 1):E2259–E2266. https://doi.org/10.1002/hed.24152

    Article  PubMed  Google Scholar 

  3. Su SY, Bell D, Ferrarotto R et al (2017) Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck 39:1671–1679. https://doi.org/10.1002/hed.24822

    Article  PubMed  Google Scholar 

  4. Elkhatib AH, Soldatova L, Carrau RL et al (2017) Role of 18F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. Laryngoscope 127:321–324. https://doi.org/10.1002/lary.26194

    Article  PubMed  Google Scholar 

  5. Cohen ZR, Marmor E, Fuller GN, DeMonte F (2002) Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus 12:e3. https://doi.org/10.3171/foc.2002.12.5.4

    Article  PubMed  Google Scholar 

  6. Czapiewski P, Kunc M, Haybaeck J (2016) Genetic and molecular alterations in olfactory neuroblastoma—implications for pathogenesis, prognosis and treatment. Oncotarget 7:52584–52596. https://doi.org/10.18632/oncotarget.9683

    Article  PubMed  PubMed Central  Google Scholar 

  7. Capper D, Engel NW, Stichel D et al (2018) DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol 136:255–271. https://doi.org/10.1007/s00401-018-1854-7

    Article  CAS  PubMed  Google Scholar 

  8. Hyams VJ (1982) Olfactory neuroblastoma (Case 6). In: Batsakis J, Hyams V, Morales A (eds) Special tumors of the head and neck. ASCP Press, Chicago, pp 24–29

    Google Scholar 

  9. Van Gompel JJ, Giannini C, Olsen KD et al (2012) Long-term outcome of esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surgery B 73:331–336. https://doi.org/10.1055/s-0032-1321512

    Article  Google Scholar 

  10. Bell D, Saade R, Roberts D et al (2015) Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 9:51–59. https://doi.org/10.1007/s12105-014-0547-3

    Article  PubMed  Google Scholar 

  11. Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571–1576. https://doi.org/10.1002/1097-0142(197603)37:3%3c1571:aid-cncr2820370347%3e3.0.co;2-l

    Article  CAS  PubMed  Google Scholar 

  12. Morita A, Ebersold MJ, Olsen KD et al (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32:706–714. https://doi.org/10.1227/00006123-199305000-00002 (discussion 714–715)

    Article  CAS  PubMed  Google Scholar 

  13. Deschler DG, Day T (2008) Pocket guide to tnm staging of head and neck cancer and neck dissection calssification, 3rd edn. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria

    Google Scholar 

  14. Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2:683–690. https://doi.org/10.1016/S1470-2045(01)00558-7

    Article  CAS  PubMed  Google Scholar 

  15. Ketcham AS, Wilkins RH, Van Buren JM, Smith RR (1963) A combined intracranial facial approach to the paranasal sinuses. Am J Surg 106:698–703. https://doi.org/10.1016/0002-9610(63)90387-8

    Article  CAS  PubMed  Google Scholar 

  16. Patel SG, Singh B, Stambuk HE et al (2012) Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B 73:208–220. https://doi.org/10.1055/s-0032-1311754

    Article  Google Scholar 

  17. Mehta GU, Hanna EY, DeMonte F, Raza SM (2018) Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien) 160:361–366. https://doi.org/10.1007/s00701-017-3437-0

    Article  Google Scholar 

  18. Hanna E, DeMonte F, Ibrahim S et al (2009) Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol-Head Neck Surg 135:1219–1224. https://doi.org/10.1001/archoto.2009.173

    Article  PubMed  Google Scholar 

  19. Feiz-Erfan I, Suki D, Hanna E, DeMonte F (2007) Prognostic significance of transdural invasion of cranial base malignancies in patients undergoing craniofacial resection. Neurosurgery 61:1178–1185. https://doi.org/10.1227/01.neu.0000306095.53388.f1 (discussion 1185)

    Article  PubMed  Google Scholar 

  20. Mays AC, Bell D, Ferrarotto R et al (2018) Early stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128:1274–1280. https://doi.org/10.1002/lary.26908

    Article  PubMed  Google Scholar 

  21. Ow TJ, Hanna EY, Roberts DB et al (2014) Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck 36:524–530. https://doi.org/10.1002/hed.23327

    Article  PubMed  Google Scholar 

  22. Jiang W, Mohamed ASR, Fuller CD et al (2017) The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6:241–247. https://doi.org/10.1016/j.prro.2015.10.023

    Article  Google Scholar 

  23. Polin RS, Sheehan JP, Chenelle AG et al (1998) The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: The University of Virginia experience. Neurosurgery 42:1029–1037. https://doi.org/10.1097/00006123-199805000-00045

    Article  CAS  PubMed  Google Scholar 

  24. Venkatramani R, Pan H, Furman WL et al (2016) Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer 63:465–470. https://doi.org/10.1002/pbc.25817

    Article  PubMed  Google Scholar 

  25. Sohrabi S, Drabick JJ, Crist H et al (2011) Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol 29:e358–e361. https://doi.org/10.1200/JCO.2010.30.9278

    Article  CAS  PubMed  Google Scholar 

  26. Kim DW, Jo YH, Jee HK et al (2004) Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 101:2257–2260. https://doi.org/10.1002/cncr.20648

    Article  CAS  PubMed  Google Scholar 

  27. Wang L, Ding Y, Wei L et al (2016) Recurrent olfactory neuroblastoma treated with cetuximab and sunitinib a case report. Medicine (United States) 95:e3536. https://doi.org/10.1097/MD.0000000000003536

    Article  Google Scholar 

  28. Preusser M, Hutterer M, Sohm M et al (2010) Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate. J Neurooncol 97:305–308. https://doi.org/10.1007/s11060-009-0027-x

    Article  CAS  PubMed  Google Scholar 

  29. London NR, Rooper LM, Bishop JA et al (2020) Expression of programmed cell death ligand 1 and associated lymphocyte infiltration in olfactory neuroblastoma. World Neurosurg 135:e187–e193. https://doi.org/10.1016/j.wneu.2019.11.112

    Article  PubMed  Google Scholar 

  30. van der Laan TP, Iepsma R, Witjes MJH et al (2016) Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. Oral Oncol 63:1–9. https://doi.org/10.1016/j.oraloncology.2016.10.002

    Article  PubMed  Google Scholar 

  31. Mitchell EH, Diaz A, Yilmaz T et al (2012) Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck 34:1372–1376. https://doi.org/10.1002/hed.21940

    Article  PubMed  Google Scholar 

  32. Turri-Zanoni M, Maragliano R, Battaglia P et al (2017) The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol 74:21–29. https://doi.org/10.1016/j.oraloncology.2017.09.010

    Article  PubMed  Google Scholar 

  33. Ferlito A, Devaney KO, Rinaldo A (2006) Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol 42:770–788. https://doi.org/10.1016/j.oraloncology.2006.01.002

    Article  PubMed  Google Scholar 

  34. Likhacheva A, Rosenthal D, Hanna E et al (2011) Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol 3:1–6. https://doi.org/10.1186/1758-3284-3-32

    Article  Google Scholar 

  35. Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227–232. https://doi.org/10.1002/1097-0142(19910715)68:2%3c227:aid-cncr2820680202%3e3.0.co;2-i

    Article  CAS  PubMed  Google Scholar 

  36. Fitzek MM, Thornton AF, Varvares M et al (2002) Neuroendocrine tumors of the sinonasal tract: results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 94:2623–2634. https://doi.org/10.1002/cncr.10537

    Article  PubMed  Google Scholar 

  37. Fried D, Zanation AM, Huang B et al (2012) Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation. Laryngoscope 122:2210–2215. https://doi.org/10.1002/lary.23463

    Article  PubMed  Google Scholar 

  38. Tanzler ED, Morris CG, Orlando CA et al (2008) Management of sinonasal undifferentiated carcinoma. Head Neck 30:595–599. https://doi.org/10.1002/hed.20748

    Article  PubMed  Google Scholar 

  39. Mendenhall WM, Mendenhall CM, Riggs CE et al (2006) Sinonasal undifferentiated carcinoma. Am J Clin Oncol Cancer Clin Trials 29:27–31. https://doi.org/10.1097/01.coc.0000189691.04140.02

    Article  Google Scholar 

  40. Musy PY, Reibel JF, Levine PA (2002) Sinonasal undifferentiated carcinoma; the search for a better outcome. Laryngoscope 112:1450–1455. https://doi.org/10.1097/00005537-200208000-00023

    Article  PubMed  Google Scholar 

  41. Rischin D, Porceddu S, Peters L et al (2004) Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 26:435–441. https://doi.org/10.1002/hed.10396

    Article  PubMed  Google Scholar 

  42. Amit M, Abdelmeguid AS, Watcherporn T et al (2019) Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma. J Clin Oncol 37:504–512. https://doi.org/10.1200/JCO.18.00353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Al-Mamgani A, van Rooij P, Mehilal R et al (2013) Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol 270:293–299. https://doi.org/10.1007/s00405-012-2008-5

    Article  PubMed  Google Scholar 

  44. Gamez ME, Lal D, Halyard MY et al (2017) Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): the mayo clinic experience. Head Neck 39:1819–1824. https://doi.org/10.1002/hed.24834

    Article  PubMed  Google Scholar 

  45. Kim BS, Vongtama R, Juillard G (2004) Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol-Head Neck Med Surg 25:162–166. https://doi.org/10.1016/j.amjoto.2003.12.002

    Article  Google Scholar 

  46. Revenaugh PC, Seth R, Pavlovich JB et al (2011) Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma. Am J Otolaryngol-Head Neck Med Surg 32:464–469. https://doi.org/10.1016/j.amjoto.2010.09.006

    Article  Google Scholar 

  47. Chen AM, Daly ME, El-Sayed I et al (2008) Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 70:338–343. https://doi.org/10.1016/j.ijrobp.2007.06.057

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Division of Neurosurgery, House Clinic, Los Angeles, CA, USA

    Gautam U. Mehta

  2. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Shaan M. Raza & Franco DeMonte

  3. Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Shirley Y. Su & Ehab Y. Hanna

  4. Department of Neurosurgey, The University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd, Room FC7.200, Unit 442, Houston, TX, 77030-4009, USA

    Franco DeMonte

Authors
  1. Gautam U. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaan M. Raza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shirley Y. Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ehab Y. Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franco DeMonte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Franco DeMonte.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict on interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehta, G.U., Raza, S.M., Su, S.Y. et al. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol 150, 367–375 (2020). https://doi.org/10.1007/s11060-020-03537-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-020-03537-1

Keywords

Search

Navigation